1. Home
  2. PPCB vs BJDX Comparison

PPCB vs BJDX Comparison

Compare PPCB & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PPCB

Propanc Biopharma Inc.

HOLD

Current Price

$0.10

Market Cap

2.3M

Sector

N/A

ML Signal

HOLD

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

N/A

Current Price

$1.92

Market Cap

2.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PPCB
BJDX
Founded
2007
2015
Country
Australia
United States
Employees
2
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PPCB
BJDX
Price
$0.10
$1.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.1M
16.6K
Earning Date
05-16-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
86.65
EPS
N/A
N/A
Revenue
N/A
$249,040.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.63
52 Week High
$10.69
$4.17

Technical Indicators

Market Signals
Indicator
PPCB
BJDX
Relative Strength Index (RSI) 41.65 49.81
Support Level N/A $1.73
Resistance Level $0.13 $2.10
Average True Range (ATR) 0.01 0.12
MACD 0.00 -0.00
Stochastic Oscillator 21.51 42.19

Price Performance

Historical Comparison
PPCB
BJDX

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Share on Social Networks: